World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
94
Citations
65285
World Ranking
548
National Ranking
253

Medicine

D-Index
94
Citations
66400
World Ranking
10235
National Ranking
5263

Overview

Thomas F. Patterson is affiliated with The University of Texas Health Science Center at San Antonio in the United States. Their body of work is primarily situated within the field of Medicine, with a significant focus on Infectious Diseases, Epidemiology, Neurology, Cell Biology, and Pharmacology.

Their research extensively covers several key topics including:

  • Antifungal resistance and susceptibility
  • Fungal infections and studies
  • COVID-19 clinical research studies
  • SARS-CoV-2 and COVID-19 research
  • Long-term effects of COVID-19
  • Plant pathogens and fungal diseases
  • Nail diseases and treatments

Patterson has published numerous papers with notable recent works such as:

  • Remdesivir for the Treatment of Covid-19 - Final Report, 2020, New England Journal of Medicine
  • Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19, 2020, New England Journal of Medicine
  • Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance, 2020, The Lancet Infectious Diseases
  • Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion, 2020, Intensive Care Medicine
  • Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology, 2021, The Lancet Infectious Diseases

Frequent co-authors collaborating with Patterson include:

  • Nathan P. Wiederhold
  • George R. Thompson
  • Luis Ostrosky-Zeichner
  • Oliver A. Cornely
  • Peter G. Pappas

Their research has been published frequently in the following venues:

  • Antimicrobial Agents and Chemotherapy
  • Open Forum Infectious Diseases
  • The Lancet Infectious Diseases
  • Clinical Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Remdesivir for the Treatment of Covid-19 - Final Report.

    John H. Beigel;Kay M. Tomashek;Lori E. Dodd;Aneesh K. Mehta

  • Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

    Ben De Pauw;Thomas J. Walsh;J. Peter Donnelly;David A. Stevens

  • Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

    Raoul Herbrecht;David W. Denning;David W. Denning;Thomas F. Patterson;John E. Bennett

  • Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

    Thomas J. Walsh;Elias J. Anaissie;David W. Denning;Raoul Herbrecht

  • Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America

    Thomas F. Patterson;George Richard Thompson;David W. Denning;Jay A. Fishman

  • Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

    S. Ascioglu;J. H. Rex;B. De Pauw;J. E. Bennett

  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach

  • Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database

    Dimitrios P. Kontoyiennis;Kieren A. Marr;Benjamin J. Park;Barbara D. Alexander

  • Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.

    Andre C Kalil;Thomas F Patterson;Aneesh K Mehta;Kay M Tomashek

  • Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)

    Peter G. Pappas;Barbara D. Alexander;David R. Andes;Susan Hadley

  • Practice Guidelines for Diseases Caused by Aspergillus

    David A. Stevens;David A. Stevens;David A. Stevens;Virginia L. Kan;Virginia L. Kan;Marc A. Judson;Marc A. Judson;Vicki A. Morrison

  • Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

    Johan A. Maertens;Issam I. Raad;Kieren A. Marr;Thomas F. Patterson

  • Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.

    Thomas F. Patterson;William R. Kirkpatrick;Mary White;John W. Hiemenz

  • Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.

    Philipp Koehler;Matteo Bassetti;Arunaloke Chakrabarti;Sharon C.A. Chen;Sharon C.A. Chen

  • Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial

    Thomas J. Walsh;Issam Raad;Thomas F. Patterson;Pranatharthi Chandrasekar

  • Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy

    Johan Maertens;Issam Raad;George Petrikkos;Marc Boogaerts

  • Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign

    Reginald E. Greene;Haran T. Schlamm;Jörg W. Oestmann;Paul Stark

  • Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment

    Maiken Cavling Arendrup;Thomas F Patterson

  • Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients

    Sofia Perea;José L. López-Ribot;William R. Kirkpatrick;Robert K. McAtee

  • Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

    Brahm H. Segal;Raoul Herbrecht;David A. Stevens;David A. Stevens;Luis Ostrosky-Zeichner

  • Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms

    Gordon Ramage;Stefano Bachmann;Thomas F. Patterson;Brian L. Wickes

Frequent Co-Authors

Nathan P. Wiederhold
Nathan P. Wiederhold The University of Texas Health Science Center at San Antonio
Michael G. Rinaldi
Michael G. Rinaldi The University of Texas Health Science Center at San Antonio
Annette W. Fothergill
Annette W. Fothergill The University of Texas Health Science Center at San Antonio
Laura K. Najvar
Laura K. Najvar The University of Texas Health Science Center at San Antonio
Jose L. Lopez-Ribot
Jose L. Lopez-Ribot The University of Texas at San Antonio
Kieren A. Marr
Kieren A. Marr Johns Hopkins University School of Medicine
David W. Denning
David W. Denning University of Manchester
John R. Graybill
John R. Graybill The University of Texas Health Science Center at San Antonio
John R. Wingard
John R. Wingard University of Florida
Thomas J. Walsh
Thomas J. Walsh Weill Cornell Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their knowledge beyond microbiology, various online degree programs offer practical pathways in healthcare and related fields. For example, students looking to enter the administrative side of healthcare can explore fast online medical billing and coding certification programs. These programs are designed to be completed quickly, preparing graduates for roles that support medical facilities with essential coding and billing tasks.

Those wanting to pursue broader healthcare roles may consider online healthcare degrees that pay well, offering a variety of options from nursing to health informatics. These degrees blend flexibility with strong career prospects, making them ideal for working professionals.

Public health is another complementary field, with many students enrolling in online public health masters programs easy to get into. These programs are accessible and provide essential training to address community health challenges, policy, and management.

Additionally, career paths focusing on child development and well-being, such as becoming a child life specialist, offer fulfilling work with competitive compensation. You can learn more about earning potential by reading about child specialist salary.

Best Scientists Citing Thomas F. Patterson

Trending Scientists

Recently Published Articles